Tmunity Reels in $100M for “Next Generation” Cancer Immunotherapy – Xconomy
Xconomy |
Tmunity Reels in $100M for “Next Generation” Cancer Immunotherapy
Xconomy Two therapies from the emerging field of engineered T cells won FDA approval to treat blood cancers last year, and the scramble is on to treat more types of cancer. Led by Usman “Oz” Azam (pictured above), the executive who once led Novartis's cell and … Tmunity nabs $100M for next-gen T-cell immunotherapies Penn immunotherapy spin-out raises $100M Cancer startup TMunity raises $100 million to advance next-generation T cell Immunotherapies to transform the … |
